Emerging Nanocarriers-based Approaches to Diagnose and Red uce Vascular Inflammation in Atherosclerosis

E-ISSN： 1875-533x|24|6|550-567

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.24, Iss.6, 2017-03, pp. : 550-567

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vascular Inflammation and Atherosclerosis: The Role of Estrogen Receptors

Current Medicinal Chemistry, Vol. 22, Iss. 22, 2015-08 ,pp. : 2651-2665

Bentham Science Publishers

Access to resources Recommend Favorite

Last Advances in Nanocarriers-Based Drug Delivery Systems for Colorectal Cancer

Current Drug Delivery, Vol. 13, Iss. 6, 2016-09 ,pp. : 830-838

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic: Inflammation in Atherosclerosis: Current Therapeutic Approaches (Executive Guest Editor: Dimitris Tousoulis)]

Current Pharmaceutical Design, Vol. 17, Iss. 37, 2011-12 ,pp. : 4087-4088

Bentham Science Publishers

Access to resources Recommend Favorite

Gliclazide, Inflammation and Atherosclerosis

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 7, Iss. 3, 2008-09 ,pp. : 224-230

Bentham Science Publishers

Access to resources Recommend Favorite

HDL and Inflammation in Atherosclerosis

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 4, Iss. 1, 2004-03 ,pp. : 51-57

Bentham Science Publishers

Access to resources Recommend Favorite